Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Personalis Inc | 11 | 0 | 0 | 0 | €5.16 | €8.69 | 68.522% |
| EyePoint Pharmaceuticals Inc. | 11 | 0 | 0 | 0 | €11.80 | €24.04 | 103.697% |
| Lightpath Techs A | 11 | 0 | 0 | 0 | €11.00 | €11.94 | 8.551% |
| Vanda Pharmaceuticals | 10 | 0 | 0 | 0 | €6.26 | €17.17 | 174.249% |
| Novartis AG ADR | 11 | 1 | 2 | 0 | €132.00 | €150.99 | 14.384% |
| Abeona Therapeutics Inc. | 10 | 0 | 1 | 0 | €4.14 | €17.20 | 315.556% |
| Ensign Group Inc. | 10 | 0 | 0 | 0 | €169.80 | €174.60 | 2.825% |
| Teladoc Health Inc | 10 | 0 | 1 | 0 | €4.35 | €8.04 | 84.994% |
| Corcept Therapeutics Inc. | 10 | 0 | 2 | 0 | €35.74 | €95.16 | 166.259% |
| Prothena Corp. plc | 11 | 1 | 0 | 0 | €9.05 | €15.80 | 74.609% |
| Esperion Therapeutis.Inc. | 10 | 0 | 0 | 0 | €1.85 | €7.81 | 321.003% |
| Simulations Plus | 9 | 0 | 0 | 0 | €12.10 | €21.39 | 76.777% |
| Bristol-Myers Squibb | 13 | 4 | 2 | 0 | €49.98 | €57.45 | 14.951% |
| XOMA Corp. | 9 | 0 | 0 | 0 | €30.00 | €38.50 | 28.325% |
| Orthofix Medical Inc. | 9 | 0 | 1 | 0 | €10.40 | €14.65 | 40.888% |
| Hologic Inc. | 9 | 0 | 0 | 0 | €66.00 | €67.46 | 2.214% |
| Enanta Pharmaceuticals Inc. | 9 | 0 | 1 | 0 | €11.90 | €17.04 | 43.160% |
| Akebia Therapeutics Inc. | 9 | 0 | 1 | 0 | €1.17 | €4.30 | 267.190% |
| Icu Medical Inc. | 9 | 0 | 0 | 0 | €107.00 | €154.35 | 44.252% |
| Illumina Inc. | 12 | 3 | 0 | 0 | €103.12 | €109.03 | 5.732% |
| Xeris Biopharma Holdings Inc. | 9 | 0 | 0 | 0 | €5.13 | €8.60 | 67.479% |
| Anika Therapeutics | 8 | 0 | 0 | 0 | €12.60 | €14.16 | 12.348% |
| Brookdale Sr Lvg | 9 | 1 | 1 | 0 | €11.40 | €13.16 | 15.423% |
| Henry Schein Inc. | 10 | 2 | 0 | 0 | €65.00 | €67.79 | 4.300% |
| ProQR Therapeutics N.V. | 8 | 0 | 1 | 0 | €1.56 | €5.61 | 260.552% |